Targeting HER2 (ERBB2) mutation-positive advanced biliary tract cancers with neratinib: Results from the phase II SUMMIT 'basket' trial Meeting Abstract
| Authors: | Harding, J. J.; Cleary, J. M.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; Park, H.; Ford, J. M.; Arnedos, M.; Stemmer, S. M.; De La Fouchardiere, C.; Ramirez, S. V.; Fountzilas, C.; Zhang, J.; Xu, F.; Lalani, A. S.; Piha-Paul, S. A.; Abou-Alfa, G. K. |
| Abstract Title: | Targeting HER2 (ERBB2) mutation-positive advanced biliary tract cancers with neratinib: Results from the phase II SUMMIT 'basket' trial |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800337 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.320 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 320 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work